Status:
COMPLETED
Study of Self-monitoring of Weight & Blood Pressure (Via patientMpower Platform) in Hemodialysis
Lead Sponsor:
patientMpower Ltd.
Collaborating Sponsors:
Health Service Executive, Ireland
Conditions:
Renal Dialysis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Pilot-scale study to assess the effect of self-monitoring using the patientMpower electronic health journal (pMp app) \[+digital weighing scales \& BP monitor\] on outcomes in ambulatory haemodialysis...
Detailed Description
Pilot-scale, prospective, open-label, randomized, two-period, cross-over intervention study. Each patient will be randomized to one of the two possible observation sequences: Sequence 1: run-in (2 w...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- Requires maintenance hemodialysis in an ambulatory care setting.
- Aged at least 18 years.
- Has daily unrestricted access to a suitable smart phone or tablet device at home.
- Has an e-mail address.
- Has home broadband and/or mobile data as part of their mobile phone service.
- Demonstrates understanding of correct use of the patientMpower application, digital weighing scales, BP monitor and other study equipment.
- Capable and willing to perform measurements (e.g. weight, BP) at home and record information on the patientMpower application on a daily basis.
- Willing to give written informed consent.
- Exclusion Criteria:
- Significant confusion or any concomitant medical condition, which would limit the ability of the patient to record symptoms or other parameters on an electronic health journal
Exclusion
Key Trial Info
Start Date :
November 7 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 8 2019
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT03403491
Start Date
November 7 2018
End Date
March 8 2019
Last Update
June 16 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Renal Dialysis Centre, Beaumont Hospital
Dublin, Ireland